Zhang Z et al. |
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. |
2015 |
Hippocampus |
pmid:25131612
|
Basavarajappa BS et al. |
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. |
2014 |
Hippocampus |
pmid:24648181
|
Hill MN et al. |
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. |
2008 |
Hippocampus |
pmid:18058925
|
Yang K et al. |
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. |
2014 |
Hippocampus |
pmid:25087967
|
Francou MM et al. |
Human sperm motility, capacitation and acrosome reaction are impaired by 2-arachidonoylglycerol endocannabinoid. |
2017 |
Histol. Histopathol. |
pmid:28585678
|
Járai Z et al. |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. |
2000 |
Hypertension |
pmid:10679517
|
Wagner JA et al. |
Mesenteric vasodilation mediated by endothelial anandamide receptors. |
1999 |
Hypertension |
pmid:9931142
|
Pulgar VM et al. |
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. |
2014 |
Hypertension |
pmid:24935942
|
Shiratsuchi A et al. |
Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis. |
2008 |
Immunol. Cell Biol. |
pmid:17909562
|
Vannacci A et al. |
Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells. |
2002 |
Inflamm. Res. |
pmid:12013387
|
Vannacci A et al. |
Nitric oxide modulates the inhibitory effect of cannabinoids on the immunological activation of guinea pig mast cells. |
2003 |
Inflamm. Res. |
pmid:12755386
|
Nagappan A et al. |
Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis. |
2018 |
Int J Mol Sci |
pmid:29570673
|
Patsenker E et al. |
Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation. |
2015 |
Int J Mol Sci |
pmid:25826533
|
Tegeder I |
Endocannabinoids as Guardians of Metastasis. |
2016 |
Int J Mol Sci |
pmid:26875980
|
Gatta-Cherifi B et al. |
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. |
2012 |
Int J Obes (Lond) |
pmid:21844878
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Côté M et al. |
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. |
2007 |
Int J Obes (Lond) |
pmid:17224929
|
Mimura T et al. |
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation. |
2012 |
Int. Arch. Allergy Immunol. |
pmid:22652530
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|